Eurolyser Diagnostics - Premium Laboratory Equipment

Comparative study: Eurolyser ASO point-of-care test is as accurate as large automated laboratory systems

Tuesday, 1. March 2016

With a conventional laboratory test, determining a patient’s ASO (Anti-Streptolysin-O) level may take up to two days. Through faster point-of-care diagnostics with a whole blood ASO test a protracted course of disease and major complications can be prevented.

The Eurolyser CUBE and smart instruments offer an ideal diagnostic solution – without any need for software updates or additional investments: Results are displayed in less than 10 minutes, which facilitates diagnostics for doctors, emergency units and smaller laboratories.

While the classic procedure involves forwarding the blood sample to a remote laboratory, the analysis through CUBE or smart instruments works on the spot and delivers reliable and accurate results. This is demonstrated in a recently published independent comparative study:

ASO comparative study

Eurolyser News

18. August 2020

SDMA: A new veterinary assay for evaluation of chronic kidney diseases...
» Read more...

17. August 2020

Phenobarbital: A next generation epilepsy monitoring assay...
» Read more...

10. December 2019

Launch of bidirectional connectivity: a feature for CUBE series instruments...
» Read more...

5. December 2019

Eurolyser is now ISO 13485:2016 certified...
» Read more...